Reviva: Announcing Completion of Enrollment of Pivotal Phase 3 Trial
Reviva (NASDAQ: RVPH) is a Phase 3 clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families. Reviva's current pipeline focuses on the central nervous system, respiratory and metabolic diseases. Reviva's pipeline currently has two drug candidates, RP5063 (Brilaroxazine) and RP1208. Both are new chemical entities discovered in-house. Topline data for pivotal Phase 3 trial evaluating brilaroxazine for the treatment of schizophrenia remains on track for mid-2023. Reviva has been granted composition of matter patents for both RP5063 and R1208 in the US, Europe, and several other countries. Visit https://www.redchip.com/stocks/RVPH to learn more. https://bit.ly/3YAo2Vr
-
39:09
Candace Owens
3 hours agoI Say Ban Porn, Cardi B Defends It | Candace Ep 8
13.2K70 -
1:37:06
2 MIKES LIVE
3 hours ago2 MIKES LIVE #80 NEWS BREAKDOWN WEDNESDAY!
8.88K -
LIVE
LFA TV
14 hours agoDems Begin Attacks on SCOTUS in Preparation for 2024 Election Steal | Trumpet Daily 6.19.24 9pm EST
413 watching -
LIVE
TENET Media
2 hours agoGuest Mark Fitzpatrick, ‘Hetero Awesomeness Month’ Bar Owner, Biden’s Amnesty Plan & More LIVE 9 ET
74 watching -
Patriots With Grit
2 hours agoHow 'Ya Gonna Call | Brett Miller
1.63K1 -
LIVE
RealitySurvival
3 hours agoNATIONAL PREPER SITREP - We Have Big Problems!
273 watching -
1:42:37
The Quartering
4 hours agoKamala Harris Replaced With Hillary, Biden's Short Circuit Problem, Fauci Admits Another Bombshell
41.7K55 -
LIVE
Akademiks
7 hours ago"The Pop Out" - Kendrick Lamar & Friends Concert
16,143 watching -
1:18:40
Dr. Drew
7 hours agoExclusive: Julian Assange's Brother Defends Wikileaks Founder From US Espionage Charges w/ Gabriel Shipton & Dr. Aimee – Ask Dr. Drew
32.5K1 -
1:00:10
Michael Feyrer Jr
10 hours agoGet Your Live Streaming Questions Answered! LIVE
10.8K3